Andy Black reappointed as Kinapse Chief Executive
Published date:
27/09/2010
27 September, 2010
London, UK
Andy Black reappointed as Kinapse Chief Executive
The Board of Directors of Kinapse Ltd. today announced that Andy Black has been appointed to succeed Shalabh Kumar as Chief Executive Officer, effective immediately.
Andy Black said “I am pleased and honoured to once again take on the Chief Executive role. My first priorities will be to ensure that Kinapse’s clients receive outstanding service, and that our people have every opportunity to fulfill their enormous potential as we continue to expand our services and operations.”
Kinapse Ltd.
About Kinapse
Kinapse provides consulting and outsourcing services to the global life sciences industries.
Our clients include many of the world’s leading pharmaceutical, biotechnology, medical device and specialty pharmaceutical companies, government organisations and life sciences service providers.
Kinapse specialises in addressing the challenges of life sciences. We understand the complex issues faced throughout the life sciences value chain and offer innovative insights, advice and service delivery to our clients.
Contact:
info@kinapse.com, +44 (0)208 946 7600
Mission Statement
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma jobs, pharma events, and pharma service company listings.
Site content is produced by our editorial team for InPharm.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
